E-LIB Suche - Ergebnisse für: Nicolau, David P

1

A New Dosing Frontier: Retrospective Assessment of Effluent..:

Lakshmipathy, Damini ; Ye, Xiaoyi ; Kuti, Joseph L...
Critical Care Explorations. 6 (2024) 4 - p. e1065 , 2024

2

Assessing the in vivo impact of novel β-lactamase inhibitor..:

Ruiz, Victor H ; Gill, Christian M ; Nicolau, David P
Journal of Antimicrobial Chemotherapy. 79 (2024) 3 - p. 546-551 , 2024

Link: https://doi.org/10.1093/..

3

Imipenem/relebactam pharmacokinetics in critically ill pati..:

Fratoni, Andrew J ; Kois, Abigail K ; Gluck, Jason A..
Journal of Antimicrobial Chemotherapy. 79 (2024) 5 - p. 1118-1125 , 2024

Link: https://doi.org/10.1093/..

4

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors..:

Fratoni, Andrew J ; Gethers, Matthew L ; Nicolau, David P.
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

5

Assessing the impact of meropenem exposure on ceftolozane/t..:

Fouad, Aliaa ; Nicolau, Samantha E ; Tamma, Pranita D...
Journal of Antimicrobial Chemotherapy. 79 (2024) 5 - p. 1176-1181 , 2024

Link: https://doi.org/10.1093/..

6

Deciphering the Efficacy of the β-Lactams in the Face of Me..:

Abdelraouf, Kamilia ; Gill, Christian M ; Gethers, Matthew...
Open Forum Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

7

Phenotypes, genotypes and breakpoints: an assessment of β-l..:

Asempa, Tomefa E ; Kois, Abigail K ; Gill, Christian M.
Journal of Antimicrobial Chemotherapy. 78 (2023) 3 - p. 636-645 , 2023

Link: https://doi.org/10.1093/..

8

Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal..:

Berry, Angela V. ; Conelius, Allison ; Gluck, Jason A...
European Journal of Drug Metabolism and Pharmacokinetics. 48 (2023) 4 - p. 437-441 , 2023

Link: https://doi.org/10.1007/..

9

Assessing the in vivo efficacy of rational antibiotics and ..:

Abouelhassan, Yasmeen ; Gill, Christian M ; Nicolau, David P
Journal of Antimicrobial Chemotherapy. 78 (2023) 8 - p. 1843-1847 , 2023

Link: https://doi.org/10.1093/..

10

Cefepime in vivo activity against carbapenem-resistant Ente..:

Fouad, Aliaa ; Gill, Christian M ; Simner, Patricia J..
Journal of Antimicrobial Chemotherapy. 78 (2023) 9 - p. 2242-2253 , 2023

Link: https://doi.org/10.1093/..

11

Directed carbapenemase testing is no longer just for Entero..:

Gill, Christian M. ; Rajkotia, Poonam ; Roberts, Amity L...
Emerging Microbes & Infections. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

12

In vivoefficacy & resistance prevention of cefiderocol in c..:

Gill, Christian M ; Santini, Debora ; Takemura, Miki...
Journal of Antimicrobial Chemotherapy. 78 (2023) 4 - p. 983-990 , 2023

Link: https://doi.org/10.1093/..

13

In vivopharmacokinetic/pharmacodynamic evaluation of cefepi..:

Abdelraouf, Kamilia ; Nicolau, David P
Journal of Antimicrobial Chemotherapy. 78 (2023) 3 - p. 692-702 , 2023

Link: https://doi.org/10.1093/..

14

Antimicrobial Activity of Tebipenem and Comparators against..:

Asempa, Tomefa E. ; Bobenchik, April M. ; Bourassa, Lori...
International Journal of Antimicrobial Agents. 61 (2023) 3 - p. 106733 , 2023

Link: https://doi.org/10.1016/..

15

2798. Difficult to treat GES and KPC harboring Pseudomonas ..:

Ruiz, Victor H ; Gill, Christian ; Nicolau, David P
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..